These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 32088913)

  • 1. Clinical Effectiveness of Levetiracetam Compared to Fosphenytoin in the Treatment of Benzodiazepine Refractory Convulsive Status Epilepticus.
    Nalisetty S; Kandasamy S; Sridharan B; Vijayakumar V; Sangaralingam T; Krishnamoorthi N
    Indian J Pediatr; 2020 Jul; 87(7):512-519. PubMed ID: 32088913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam compared with phenytoin or fosphenytoin in benzodiazepine-refractory pediatric status epilepticus.
    Long B; Gottlieb M
    Acad Emerg Med; 2022 Jan; 29(1):125-127. PubMed ID: 33999500
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V; Rameshkumar R; Mahadevan S
    Indian Pediatr; 2020 Mar; 57(3):222-227. PubMed ID: 32198861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial.
    Coralic Z; Kapur J; Olson KR; Chamberlain JM; Overbeek D; Silbergleit R
    Ann Emerg Med; 2022 Sep; 80(3):194-202. PubMed ID: 35718575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy Of Levetiracetam Versus Phenytoin As A Second-Line Antiepileptic Drug In The Management Of Benzodiazepine-Refractory Status Epilepticus Among Children.
    Naeem B; Ashfaq M; Qureshi MA
    J Ayub Med Coll Abbottabad; 2023; 35(3):410-414. PubMed ID: 38404082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
    Sathe AG; Mishra U; Ivaturi V; Brundage RC; Cloyd JC; Elm JJ; Chamberlain JM; Silbergleit R; Kapur J; Lowenstein DH; Shinnar S; Cock HR; Fountain NB; Babcock L; Coles LD
    J Clin Pharmacol; 2021 Jun; 61(6):763-768. PubMed ID: 33336359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Effectiveness of Levetiracetam Compared to Fosphenytoin in the Treatment of Benzodiazepine Refractory Convulsive Status Epilepticus: Correspondence.
    Panda PK; Sharawat IK
    Indian J Pediatr; 2021 Feb; 88(2):198-199. PubMed ID: 32504453
    [No Abstract]   [Full Text] [Related]  

  • 12. Levetiracetam versus Fosphenytoin in Pediatric Convulsive Status Epilepticus: A Randomized Controlled Trial.
    Handral A; Veerappa BG; Gowda VK; Shivappa SK; Benakappa N; Benakappa A
    J Pediatr Neurosci; 2020; 15(3):252-256. PubMed ID: 33531940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of benzodiazepine-resistant status epilepticus: Systematic review and network meta-analyses.
    Jain P; Aneja S; Cunningham J; Arya R; Sharma S
    Seizure; 2022 Nov; 102():74-82. PubMed ID: 36209676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
    Nakamura K; Marushima A; Takahashi Y; Kimura A; Asami M; Egawa S; Kaneko J; Kondo Y; Yonekawa C; Hoshiyama E; Yamada T; Maruo K; Inoue Y;
    Trials; 2021 May; 22(1):317. PubMed ID: 33934714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis.
    Abdelgadir I; Hamud A; Kadri A; Akram S; Pullattayil A; Akobeng AK; Powell C
    Arch Dis Child; 2021 Apr; 106(5):470-476. PubMed ID: 33060105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam Versus Phenytoin or Fosphenytoin for Second-Line Treatment of Pediatric Status Epilepticus: A Meta-Analysis.
    Klowak JA; Hewitt M; Catenacci V; Duffett M; Rochwerg B; Jones K; Choong K
    Pediatr Crit Care Med; 2021 Sep; 22(9):e480-e491. PubMed ID: 33710073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Angurana SK; Suthar R
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34089322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
    Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N
    Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.